Davide Giuseppe Ribaldone

112PUBLICATIONS
261CO-AUTHORS
Environmental epidemiologyInnate immunityRheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (112)

|Jul 15, 2026
Real-World Safety and Herpes Zoster Outcomes After Recombinant Zoster Vaccination in Inflammatory Bowel Disease.

|Mar 14, 2026
Sampling Extension, Chronic Infiltrates, and Eosinophils: Support for the Evaluation of Histological Healing in Inflammatory Bowel Disease with Endoscopic Remission.

Gabriella Canavese, Enrico Costantino Falco, Davide Giuseppe Ribaldone

|Feb 18, 2026
Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

Franco Scaldaferri, Federica Di Vincenzo, Marina Aloi

|Feb 13, 2026
Risk Factors for Inadequate Bowel Preparation Before Colonoscopy in Patients with Ulcerative Colitis in Clinical and Endoscopic Remission: A Multicenter Retrospective Cohort Study.

Davide Scalvini, Stiliano Maimaris, Elisa Stasi

|Nov 13, 2025
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study.

Giammarco Mocci, Antonio Tursi, Franco Scaldaferri

|Oct 30, 2025
IL10 rs1800896 Genetic Variant Predicts Biochemical Remission in Inflammatory Bowel Disease Patients Undergoing Biologic Therapy.

Michela Helga Falzone, Davide Giuseppe Ribaldone, Martina Buglione

Pageof 19

Frequent Collaborators

45 joint publications

Gian Paolo Caviglia

42 joint publications

Giorgio Saracco

27 joint publications

Angelo Armandi

19 joint publications

Chiara Rosso